Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials

Jonathan A. Bernstein, J. Christian Virchow, Kevin R. Murphy, Jorge Máspero, Joshua Jacobs, Yochai Adir, Marc Humbert, Mario Castro, Douglas Marsteller, Jennifer McElhattan, Lisa Hickey, Margaret Garin, Rebecca Vanlandingham, Guy Brusselle